Trial · NCT03896295
Results by group536
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 536
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Placebo-Nipocalimab | 4 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Nipocalimab-Nipocalimab | 18 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Nipocalimab (All Participants) | 22 | Participants | ||
| Number of Participants With Serious Adverse Events (SAEs) | Placebo-Nipocalimab | 1 | Participants | ||
| Number of Participants With Serious Adverse Events (SAEs) | Nipocalimab-Nipocalimab | 4 | Participants | ||
| Number of Participants With Serious Adverse Events (SAEs) | Nipocalimab (All Participants) | 5 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events of Special Interest (AESIs) | Placebo-Nipocalimab | 1 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events of Special Interest (AESIs) | Nipocalimab-Nipocalimab | 1 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events of Special Interest (AESIs) | Nipocalimab (All Participants) | 2 | Participants | ||
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Placebo-Nipocalimab | Pulse rate: <=50 bpm with >=15 bpm decrease from baseline | 0 | Participants | |
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Nipocalimab-Nipocalimab | Pulse rate: <=50 bpm with >=15 bpm decrease from baseline | 0 | Participants | |
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Nipocalimab (All Participants) | Pulse rate: <=50 bpm with >=15 bpm decrease from baseline | 0 | Participants | |
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Placebo-Nipocalimab | Pulse rate: >= 120 bpm with >=15 bpm increase from baseline | 0 | Participants | |
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Nipocalimab-Nipocalimab | Pulse rate: >= 120 bpm with >=15 bpm increase from baseline | 0 | Participants | |
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Nipocalimab (All Participants) | Pulse rate: >= 120 bpm with >=15 bpm increase from baseline | 0 | Participants | |
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Placebo-Nipocalimab | SBP: <= 90 mmHg with >= 20 mmHg decrease from baseline | 0 | Participants | |
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Nipocalimab-Nipocalimab | SBP: <= 90 mmHg with >= 20 mmHg decrease from baseline | 1 | Participants | |
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Nipocalimab (All Participants) | SBP: <= 90 mmHg with >= 20 mmHg decrease from baseline | 1 | Participants | |
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Placebo-Nipocalimab | SBP: >= 160 mmHg with >= 20 mmHg increase from baseline | 0 | Participants | |
| Number of Participants With Treatment-emergent Abnormal Vital Signs | Nipocalimab-Nipocalimab | SBP: >= 160 mmHg with >= 20 mmHg increase from baseline | 1 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03896295/results